Immunization with UV-induced apoptotic cells generates monoclonal antibodies against proteins differentially expressed in hepatocellular carcinoma cell lines

Hybridoma

Volumn 26, Issue 2, 2007, Pages 55-61

  Celikkaya, Hilal ^a,c   Ciraci, Ceren ^a,d   Oztas, Emin ^a,b   Avci, M Ender ^a   Ozturk, Mehmet ^a   Yagci, Tamer ^a  

^a BILKENT UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; IMMUNOGLOBULIN G3; LIGAND; MONOCLONAL ANTIBODY; PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER PATIENT; CELL ASSAY; CELL LINE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDOMA; IMMUNIZATION; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MODULATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; ULTRAVIOLET IRRADIATION; UPREGULATION; VALIDATION STUDY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HUMANS; HYBRIDOMAS; IMMUNIZATION; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; ULTRAVIOLET RAYS;

EID: 34247553671     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2006.047     Document Type: Article

References (33)

1. Bruix J, Boix L, Sala M, and Llovet JM: Focus on hepatocellular carcinoma. Cancer Cell 2004;5:215-219.
2. Llovet JM, Burroughs A, and Bruix J: Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
3. Parkin DM, Bray F, Ferlay J, and Pisani P: Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 2001;94:153-156.
4. Bruix J, Barrera JM, Calvet X, et al: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;2:1004-1006.
5. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, and Kawashima T: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-1801.
6. Bolondi L: Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003;39:1076-1084.
7. Lin DY and Liaw YF: Optimal surveillance of hepatocellular carcinoma in patients with chronic viral hepatitis. J Gastroen Hepatol 2005;16:715-717.
8. Marrero JA and Fok ASF: Newer markers for hepatocellular carcinoma. Gastroenterology 2004;127:S113-S119.
9. Lopez JB: Recent developments in the first detection of hepatocellular carcinoma. Clin Biochem Rev 2005;26:65-79.
10. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 2000;100:57-70.
11. Reed JC: Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol 1999;11:68-75.
12. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordón-Cardó C, and Lowe SW: Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001;409:207-211.
13. Sayan BS, Ince G, Sayan AE, and Ozturk M: NAPO as a novel marker for apoptosis. J Cell Biol 2001;155:719-724.
14. Harlow E and Lane D: Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1988. pp. 196-214.
15. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
16. Inagaki M, Moustakas A, Lin HY, Lodish HF, and Carr BI: Growth inhibition by transforming growth factor β (TGF-β) type I is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc Natl Acad Sci USA 1993;90:5359-5363.
17. Arad U, Axelrod J, Ben-nun-Shaul O, Oppenheim A, and Galun E: Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors. J Hepatol 2004;40:520-526.
18. Liu Y, Takahashi S, Ogasawara H, Seo HG, Kawagoe M, Hirasawa F, Guo N, Ueno Y, Kameda T, and Sugiyama T: Protection of hepatocytes from apoptosis by a novel substance from actinomycetes culture medium. Biomed Res 2005;26:9-14.
19. Ozturk N, Erdal E, Mumcuoglu M, Akcali KC, Yalcin O, Senturk S, Arslan-Ergul A, Gur B, Yulug I, Cetin-Atalay R, Yakicier C, Yagci T, Tez M, and Ozturk M: Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells. Proc Natl Acad Sci USA 2006;103:2178-2183.
20. Nagamori S, Hasumura S, Matsuura T, Aizaki H, and Kawada M: Developments in bioartificial liver research: concepts, performance, and applications. J Gastroenterol 2000;35:493-503.
21. Aizaki H, Nagamori S, Matsuda M, Kawakami H, Hashimoto O, Ishiko H, Kawada M, Matsuura T, Hasumura S, Matsuura Y, Suzuki T, and Miyamura T: Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor. Virology 2003;314:16-25.
22. Mizejewski GJ: Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants. Exp Biol Med 2001;226:377-408.
23. Lee JS and Thorgeirsson SS: Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology 2002;35:1134-1143.
24. Kawai HF, Kanaeko S, Honda M, Shirota Y, and Kobayashi K: α-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. Hepatology 2001;33:676-691.
25. Nakatsura T, Yoshitake Y, Senju S, Monji M, Komori H, Motomura Y, Hosaka S, Beppu T, Ishiko T, Kamohara H, Ashihara H, Katagiri T, Furukawa Y, Fujiyama S, Ogawa M, Nakamura Y, and Nishimura Y: Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Bioph Res Co 2003;306:16-25.
26. Hendrick JP and Hartl F: Molecular chaperone functions of heat-shock proteins. Ann Rev Biochem 1993;62:349-384.
27. Luk JM, Lam CT, Siu AFM, Lam BY, Ng IOL, Hu MY, Che CM, and Fan ST: Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 2006;6:1049-1057.
28. Lewis ML and Hughes-Fulford M: Regulation of heat shock protein message in Jurkat cells cultured under serum-starved and gravity-altered conditions. J Cell Biochem 2000;77:127-134.
29. Kuwabara H, Yoneda M, Hayasaki H, Nakamura T, and Mori H: Glucose regulated proteins 78 and 75 bind to the receptor for hyaluronan mediated motility in interphase microtubules. Biochem Bioph Res Co 2006;339:971-976.
30. McKay BC, Stubbert LJ, Fowler CC, Smith JM, Cardamore RA, and Spronck JC: Regulation of ultraviolet light-induced gene expression by gene size PNAS 2004;101:6582-6586.
31. Wu S, Hu Y, Wang JL, Chatterjee M, Shi Y, and Kaufman RJ: Ultraviolet light inhibits translation through activation of the unfolded protein response kinase PERK in the lumen of the endoplasmic reticulum. J Biol Chem 2002;277:18077-18083.
32. Deng J, Harding HP, Raught B, Gingras AC, Berlanga JJ, Scheuner D, Kaufman RJ, Ron D, and Sonenberg N: Activation of GCN2 in UV-irradiated cells inhibits translation. Curr Biol 2002;12:1279-1286.
33. Koch-Paiz CA, Amundson SA, Bittner ML, Meltzer PS, Fornace AJ Jr: Functional genomics of UV radiation responses in human cells. Mutat Res 2004;549:65-78.